4.8 Article

Common 5p15.33 and 6p21.33 variants influence lung cancer risk

Journal

NATURE GENETICS
Volume 40, Issue 12, Pages 1407-1409

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.273

Keywords

-

Funding

  1. Cancer Research UK [A1298/A8780]
  2. HEAL
  3. Sanofi-Aventis
  4. US NIH [P50CA70907, R01CA121197, R01CA133996]
  5. MRC [G0000934] Funding Source: UKRI
  6. Medical Research Council [G0000934] Funding Source: researchfish
  7. NATIONAL CANCER INSTITUTE [R01CA121197, P50CA070907, R01CA133996] Funding Source: NIH RePORTER

Ask authors/readers for more resources

We conducted a genome-wide association (GWA) study of lung cancer comparing 511,919 SNP genotypes in 1,952 cases and 1,438 controls. The most significant association was attained at 15q25.1 (rs8042374; P = 7.75 x 10(-12)), confirming recent observations. Pooling data with two other GWA studies (5,095 cases, 5,200 controls) and with replication in an additional 2,484 cases and 3,036 controls, we identified two newly associated risk loci mapping to 6p21.33 (rs3117582, BAT3-MSH5; P-combined 4.97 x 10(-10)) and 5p15.33 (rs401681, CLPTM1L; P-combined 7.90 x 10(-9)).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available